Live Breaking News & Updates on Disease Activity

Stay updated with breaking news from Disease activity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study

New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

North Chicago , United States , Roopal Thakkar , J Clin Dermatol , Exchange Commission , Program To Assess Adverse Events , Abbvie Inc , Eczema Area , Severity Index , Worst Pruritus Numerical Rating Scale , Atopic Dermatitis , Important Safety , Medication Guide , Consumer Brief Summary , Full Prescribing Information , Allergan Aesthetics , Private Securities Litigation Reform Act , Quarterly Reports , Global Epidemiology , Ann Nutr , Nat Rev Dis , Adolescents With Uncontrolled Moderate , Severe Atopic Dermatitis , Term Efficacy , Moderate To Severe Atopic Dermatitis , Results Through Week ,

Proposed Golimumab Biosimilar AVT05 Meets Primary Endpoints in Moderate to Severe RA

At the end of the trial, the study met its primary outcome, indicating therapeutic equivalence between the biosimilar (AVT05) and reference golimumab. ....

Robert Wessman , Momna Ali , Cameroni Alvotech , Rheumatology Informatics System , Clinical Disease Activity Index , Disease Activity , Rheumatoid Arthritis , Globenewswire News ,

Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis

Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Kori Wallace , Program To Assess Adverse Events , Exchange Commission , Abbvie Inc , Arthritis Foundation , Giant Cell Arteritis , Important Safety , Medication Guide , Consumer Brief Summary , Mississippi River , Allergan Aesthetics , Private Securities Litigation Reform Act , Quarterly Reports , Giant Cell , Accessed April , Takaysu Arteritis , Assess Adverse Events , Disease Activity , Adult Participants With Moderate , Severe Systemic Lupus Erythematosus , Assess Change , Adverse Events , Oral Upadacitinib , Adolescent Participants With Moderate , Severe Hidradenitis Suppurativa Who Have Failed ,

Deucravacitinib Improves Patient-Reported Outcomes in Active Psoriatic Arthritis

The selective, allosteric tyrosine kinase 2 inhibitor demonstrated significant and clinically meaningful improvements in PROs versus placebo in a phase 2 trial of patients with PsA. ....

American College Of Rheumatology , Health Assessment Questionnaire , Short Form Health , Stanford University School Of Medicine , American College , Health Assessment Questionnaire Disability Index , Physical Component Summary , Vibeke Strand , Stanford University School , Classification Criteria , Psoriatic Arthritis , Psoriatic Impact , Functional Assessment , Chronic Illness Therapy Fatigue , Patient Global Assessment , Disease Activity ,

Impact of TNFi, IL-17Ai Treatments on Psoriatic Arthritis Biomarkers

These data highlight the changes observed in cytokine levels among both PsA treatment responders and non-responders. ....

Marie Skougaard , Parker Institute , Copenhagen University Hospital Bispebjerg , Parker Institute Marie Skougaard , Psoriasis Area Severity Index , Disease Activity , Psoriatic Arthritis , Visual Analog Scale ,